Poll Shows Alexandria Ocasio-Cortez Within Striking Distance Of Defeating JD Vance In 2028 Presidential Race
Representative Alexandria Ocasio-Cortez is emerging as a serious contender for the 2028...
Read MoreEwan is a reporter at the Foreign Policy Journal, primarily covering US current affairs and news related to NYSE-listed stocks. He has over two decades of experience in journalism and digital publishing.
Posted by Ewan Scott | Aug 31, 2026 | Featured, News & Analysis, Politics |
Representative Alexandria Ocasio-Cortez is emerging as a serious contender for the 2028...
Read MorePosted by Ewan Scott | Aug 31, 2026 | Featured, Law and Regulation, News & Analysis, Politics |
President Donald Trump has escalated his campaign against broadcast media, saying he will report...
Read MorePosted by Ewan Scott | Aug 31, 2026 | Economy & Business, Featured, News & Analysis, UK |
HSBC Holdings (LSE: HSBA) has delivered one of the most impressive performances among FTSE 100...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
D-Wave Quantum (NASDAQ: QBTS) occupies a rare position in the technology sector as a pure-play...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
Marvell Technology (NASDAQ: MRVL) shares fell sharply after the company’s latest earnings...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
Microsoft (NASDAQ: MSFT) has built one of the most durable cash-generation engines in enterprise...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
Netflix (NASDAQ: NFLX) shares have surged 16% over the past five weeks, offering some relief to...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
Once a business intelligence software company, Strategy (NASDAQ: MSTR) has become one of the most...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, Law and Regulation, News & Analysis |
Eli Lilly (NYSE: LLY) has secured Food and Drug Administration approval for its diabetes drug...
Read MorePosted by Ewan Scott | Aug 30, 2026 | Economy & Business, Featured, News & Analysis |
IREN Limited (NASDAQ: IREN) reported a $638.8 million impairment charge tied largely to older...
Read More